Fluorine, an essential element for medicinal chemistry;Le fluor : un élément essentiel en chimie médicinale

Annales Pharmaceutiques Francaises

Volumn 66, Issue 1, 2008, Pages 56-59

  Bonnet Delpon, D ^a  

^a UNIVERSITÉ PARIS SUD   (France)

Author keywords

Drugs; Enzyme inhibitors; Fluorine; Metabolism

Indexed keywords

6 [4 [(4,4,4 TRIFLUOROBUTYL)THIO] 1,2,5 THIADIAZOL 3 YL] 1 AZABICYCLO[3.2.1]OCTANE; ANALGESIC AGENT; ARTEMISININ DERIVATIVE; DESOXOARTEMISININ; DIDANOSINE; FLUORINE; ORGANOFLUORINE DERIVATIVE; UNCLASSIFIED DRUG; FLUORINE DERIVATIVE; PROTEIN;

AEROBIC METABOLISM; ARTICLE; CHEMICAL ANALYSIS; DRUG INDUSTRY; DRUG STRUCTURE; HYDROLYSIS; CHEMISTRY;

CHEMISTRY, PHARMACEUTICAL; DRUG INDUSTRY; FLUORINE; FLUORINE COMPOUNDS; PROTEINS;

EID: 47549108113     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharma.2007.12.001     Document Type: Article

References (15)

1. Fried J., and Sabo E.F. 9α-fluoro derivatives of cortisone and hydrocortisone. J Am Chem Soc 76 (1954) 1455
2. O'Hagan D., and Harper D.B. Fluorine-containing natural products. J Fluor Chem 100 (1999) 127
3. Dong C.J., Huang F.L., Deng H., Schaffrath C., Spencer J.B., O'Hagan D., et al. Crystal structure and mechanism of a bacterial fluorinating enzyme. Nature 427 (2004) 561
4. Bégué J.P., and Bonnet-Delpon D. Chimie bioorganique et médicinale du fluor (2005), EDP-Sciences/CNRS Édition, Paris
5. Edwards P.N. In: Banks R.E., Smart B.E., and Tatlow J.C. (Eds). Organofluorine chemistry: principles and commercial applications (1994), Plenum Press, New York 502-509
6. Böhm H.J., Banner D., Bendels S., Kansy M., Kuhn B., Müller K., et al. Fluorine in medicinal chemistry. ChemBioChem 5 (2004) 637
7. Mitch C.H., Brown T.J., Bymaster F.P., Calligaro D.O., Dieckman D., Merrit L., et al. Muscarinic analgesics with potent and selective effects on the gastrointestinal tract: potential application for the treatment of irritable bowel syndrome. J Med Chem 40 (1997) 538
8. Ford Jr. H., Siddiqui M.A., Driscoll J.S., Marquez V.E., Kelley J.A., Mitsuya H., et al. Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 2. 6-halo- and 6-alkoxy prodrugs of 2′-beta-fluoro-2′,3′-dideoxyinosine. J Med Chem 38 (1995) 1189
9. Jeannot F., Mathé C., and Gosselin G. Synthesis and antiviral evaluation of 3′-C-trifluoromethyl nucleoside derivatives bearing adenine as the base. Nucleos Nucleot Nucl Acids 20 (2001) 755
10. Chorki F., Grellepois F., Ourévitch M., Crousse B., Charneau S., Grellier P., et al. Orally active antimalarials: hydrolytically stable derivatives of 10-trifluoromethyl anhydrodihydroartemisinin. J Med Chem 47 (2004) 1423
11. Biffinger J.C., Kim H.W., and DiMagno S.G. The polar hydrophobicity of fluorinated compounds. ChemBioChem 5 (2004) 622
12. Gelb M.H., Svaren J.P., and Abeles R.H. Fluoro ketone inhibitors of hydrolytic enzymes. Biochemistry 24 (1985) 1813
13. Imperiali B., and Abeles R.H. Inhibition of serine proteases by peptidyl fluoromethyl ketones. Biochemistry 25 (1986) 3760
14. Namchuk M, Braun C, Withers SG. Biomedical frontiers of fluorine chemistry. In: Ojima I, Mc Carthy JR, Welch JT, editors. ACS Symp Ser 639. Washington DC; 1996. p. 279.
15. McCarthy JR, Sunkara PS, Matthews DP, Bitonti AJ, Jarvi EJ, Sabol JS, et al. Biomedical frontiers of fluorine chemistry. In: Ojima I, Mc Carthy JR, Welch JT, editors. ACS Symp. Ser. 639. Washington DC; 1996. p. 246.